Also, glial fibrillary acidic protein (GFAP), an intermediate astrocyte cytoskeletal protein indicating astrocyting activation, has been recently shown to be higher in progressive MS than in RRMS and correlate with disability. The gene discussed is GFAP; the disease is myeloid sarcoma.